Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Cell-based Assays Market Worth USD 46.87 Billion by 2035 | SNS Insider

globenewswire.com
TMO Thermo Fisher Scientific is mentioned as a major industry participant in the North American Cell-based Assays Market, indicating its involvement in this growing sector. The article does not provide specific sentiment towards the company's performance. BDX BD Biosciences is identified as a key player in the North American Cell-based Assays Market. The article's focus on market expansion and growth drivers implies a positive outlook for companies involved in this space, though no direct sentiment is given. BIO Bio-Rad Laboratories is named as a significant industry participant in the North American Cell-based Assays Market. The article's overall positive tone regarding the market's growth suggests a favorable environment for Bio-Rad, but no specific sentiment is expressed.

Cell-based Assays Market Worth USD 46.87 Billion by 2035 | SNS Insider Austin, United States, June 25, 2026 (GLOBE NEWSWIRE) -- The Cell-based Assays Market Size was valued at USD 20.13 Billion in 2025 and is projected to reach USD 46.87 Billion by 2035, expanding at a CAGR of 8.36% during 2026–2035, according to SNS Insider. Factors such as growing application of cell-based screening technologies in drug discovery process, increasing investments in biologics and precision medicine, increasing adoption of 3D cell cultures, and growing demand for predictive toxicity testing have fueled the market growth of Cell-based Assays Market.

Get a Sample Copy of the Cell-based Assays Market Report 2026–2035 @ https://www.snsinsider.com/sample-request/6254

Cell-based Assays Market Growth Driven by Drug Discovery, 3D Cell Culture, and High-Throughput Screening

The increasing use of cell-based assays throughout the drug discovery and development process is emerging as one of the most significant growth drivers for the market. Pharmaceutical and biotechnology companies are increasingly shifting from traditional biochemical assays toward functional cellular models that offer greater physiological relevance and predictive accuracy. Cell-based assays provide valuable insights into target engagement, cellular signaling pathways, drug efficacy, toxicity, and mechanism of action, enabling more informed decision-making during early-stage development.

Simultaneously, advancements in three-dimensional cell culture systems, organoids, and organ-on-chip technologies are transforming preclinical research capabilities. These next-generation platforms better replicate human disease biology and improve the predictive validity of drug response studies. The integration of artificial intelligence-powered imaging and automated laboratory workflows is further enhancing assay throughput, reproducibility, and data interpretation, creating significant opportunities across pharmaceutical, biotechnology, and academic research sectors.

Leading Market Players Listed in this Report are:

Segmentation Analysis:

By Products & Services

The Assay Kits segment dominated the Cell-based Assays Market in 2025, accounting for approximately 38.55% of total market revenue attributed to the widespread adoption of ready-to-use and pre-validated assay solutions that simplify workflow management globally. The Reagents segment is expected to register the fastest growth during the forecast period owing to surging utilization of advanced cell models, stem cell research applications, gene editing technologies, and three-dimensional culture systems worldwide.

By Application

The Drug Discovery segment held the largest market share in 2025 owing to extensive utilization of cell-based assays across target identification, lead optimization, efficacy testing, mechanistic studies, and safety assessment globally. The Basic Research segment is projected to witness the fastest growth during the forecast period owing to surging government funding for life sciences research globally.

By End-Use

The Pharmaceutical & Biotechnology Companies segment accounted for the largest share of the Cell-based Assays Market in 2025 due to increasing drug discovery programs and growing investments in biologics, cell therapies, and precision medicine globally. The Contract Research Organizations (CROs) segment is expected to be the fastest-growing category during the forecast period owing to the increasing outsourcing of drug discovery globally.

Regional Insights:

North America dominated the global Cell-based Assays Market in 2025. The region benefits from strong pharmaceutical and biotechnology R&D investment, extensive academic research infrastructure, favorable regulatory support for alternative testing methods, and the presence of major industry participants including Thermo Fisher Scientific, Agilent Technologies, BD Biosciences, Promega Corporation, and Bio-Rad Laboratories.

The U.S. Cell-based Assays Market was valued at USD 3.44 Billion in 2025 and is projected to reach USD 7.31 Billion by 2035, owing to significant NIH funding, non-animal testing techniques being increasingly adopted and greater investments in the R&D of drugs.

The Europe Cell-based Assays Market is expected to expand from USD 5.62 Billion in 2025 to USD 12.49 Billion by 2035, driven by increasing biologics research, implementation of alternative testing technologies, and rising demand for advanced cellular models across drug development programs.

The Asia-Pacific region is projected to be the fastest-growing market throughout the forecast period. Rapid expansion of pharmaceutical R&D activities, increasing CRO investments, growing biotechnology industries, and rising government support for biomedical research across China, India, Japan, South Korea, and Australia are driving substantial market growth.

Purchase the Cell-based Assays Market Report with Detailed Competitive Analysis and Forecast to 2035 @ https://www.snsinsider.com/checkout/6254

Recent Developments:

Exclusive Sections of the Report (The USPs):

Cell-based Assays Market Report Scope

Related Market Reports

ATP Assays Market Size Report 2026

Apoptosis Assay Market Growth Analysis 2026

High Throughput Screening Market Trends Report 2026

Single-cell Analysis Market Size Outlook 2026

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.